SetPoint Medical Obtains $27,000,000 New Funding

  • Feed Type
  • Date
    8/8/2013
  • Company Name
    SetPoint Medical
  • Mailing Address
    27441 Tourney Road Valencia, CA 91355
  • Company Description
    The company develops neuron-modulation platform technology to treat chronic diseases.
  • Website
    http://www.setpointmedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $27,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The proceeds of the financing will be used to expand ongoing clinical development of the SetPoint bioelectronics therapy approach in rheumatoid arthritis and Crohn’s disease and advance development of the SetPoint proprietary neuromodulation platform.
  • M&A Terms
  • Venture Investor
    Covidien Ventures
  • Venture Investor
    GlaxoSmithKline
  • Venture Investor
    Boston Scientific Corporation
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    Foundation Medical Partners
  • Venture Investor
    Topspin Partners

By posting a comment, you agree to our terms and conditions.